Related Experiment Video

Updated: Aug 23, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Vaccines for other neonatal infections: neonatal BCG vaccination against tuberculosis

Warwick J Britton1

  • 1Centenary Institute of Cancer Medicine and Cell Biology and Department of Medicine, University of Sydney, Bld DO6, Sydney, NSW 2006, Australia. wbritton@med.usyd.edu.au

Expert Review of Vaccines
|July 24, 2004
PubMed

Insights

This research reviews advancements in vaccines for bacterial and mycobacterial infections in newborns. It highlights progress in using pertussis, pneumococcus, group B streptococcus, and bacille Calmette-Guérin vaccines to prevent neonatal infections.

Area of Science:

  • Immunology
  • Neonatal Infectious Diseases
  • Vaccinology

Background:

  • Neonatal infections pose significant risks to infant health and survival.
  • Vaccines are crucial for preventing infectious diseases in vulnerable populations.

Purpose of the Study:

  • To summarize current progress in vaccine development and application for neonatal infections.
  • To review vaccines targeting bacterial and mycobacterial pathogens in newborns.

Main Methods:

  • Literature review of recent studies on vaccine efficacy and implementation.
  • Analysis of vaccine strategies against pertussis, pneumococcus, group B streptococcus, and bacille Calmette-Guérin.

Main Results:

  • Vaccines against pertussis, pneumococcus, and group B streptococcus show promise in reducing neonatal bacterial infections.
  • Bacille Calmette-Guérin vaccination continues to be evaluated for its role in preventing mycobacterial infections in neonates.

Conclusions:

  • Vaccination is a key strategy for preventing neonatal infections.
  • Continued research and implementation of vaccines are essential for improving infant health outcomes.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Vaccinations01:51

Vaccinations

Overview
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...